Hemosol

HML-T

0.00
0.00 (0.00%)
This company is not ACTIVE.

Analysis and Opinions about HML-T

Signal
Opinion
Expert
DON'T BUY
DON'T BUY
January 23, 2002
Have ahd difficulties in their trials. May have a weak cash position.
Show full opinionHide full opinion
Hemosol (HML-T)
January 23, 2002
Have ahd difficulties in their trials. May have a weak cash position.
DON'T BUY
DON'T BUY
January 9, 2002
Starting to move up, but prefers to wait for the product to start selling.
Show full opinionHide full opinion
Hemosol (HML-T)
January 9, 2002
Starting to move up, but prefers to wait for the product to start selling.
BUY
BUY
December 31, 2001
A long term situation, but expects it will do OK.
Show full opinionHide full opinion
Hemosol (HML-T)
December 31, 2001
A long term situation, but expects it will do OK.
BUY
BUY
December 28, 2001
Sees it going up. Use a $6.90 stop loss. Expects it to get to $8.75 at which time it should be looked at again.
Show full opinionHide full opinion
Hemosol (HML-T)
December 28, 2001
Sees it going up. Use a $6.90 stop loss. Expects it to get to $8.75 at which time it should be looked at again.
WAIT
WAIT
December 21, 2001
A lot of competition in blood substitutes.
Show full opinionHide full opinion
Hemosol (HML-T)
December 21, 2001
A lot of competition in blood substitutes.
DON'T BUY
DON'T BUY
December 6, 2001
Prefers other companies that have earnings. Might buy at $3.
Show full opinionHide full opinion
Hemosol (HML-T)
December 6, 2001
Prefers other companies that have earnings. Might buy at $3.
DON'T BUY
DON'T BUY
November 28, 2001
Wait for FDA approval.
Show full opinionHide full opinion
Hemosol (HML-T)
November 28, 2001
Wait for FDA approval.
DON'T BUY
DON'T BUY
November 27, 2001
If you own, hold.
Show full opinionHide full opinion
Hemosol (HML-T)
November 27, 2001
If you own, hold.
DON'T BUY
DON'T BUY
November 26, 2001
Watch how the trials go.
Show full opinionHide full opinion
Hemosol (HML-T)
November 26, 2001
Watch how the trials go.
WEAK BUY
WEAK BUY
November 22, 2001
Analysts are expecting a large upside. Will take time to get through the FDA phases.
Show full opinionHide full opinion
Hemosol (HML-T)
November 22, 2001
Analysts are expecting a large upside. Will take time to get through the FDA phases.
DON'T BUY
DON'T BUY
November 5, 2001
Wait for FDA approval to go through. Will be a good product.
Show full opinionHide full opinion
Hemosol (HML-T)
November 5, 2001
Wait for FDA approval to go through. Will be a good product.
BUY
BUY
October 25, 2001
A worthwhile stock to own a little bit. At a good price.
Show full opinionHide full opinion
Hemosol (HML-T)
October 25, 2001
A worthwhile stock to own a little bit. At a good price.
WEAK BUY
WEAK BUY
October 11, 2001
Good product. Phase 3is delayed for a year. Lots of competition, but room for all. Speculative.
Show full opinionHide full opinion
Hemosol (HML-T)
October 11, 2001
Good product. Phase 3is delayed for a year. Lots of competition, but room for all. Speculative.
DON'T BUY
DON'T BUY
September 7, 2001
Will take a while for the product to come on stream. Has strong competition.
Show full opinionHide full opinion
Hemosol (HML-T)
September 7, 2001
Will take a while for the product to come on stream. Has strong competition.
DON'T BUY
DON'T BUY
September 5, 2001
High valuation and delay on trials was a downer.
Show full opinionHide full opinion
Hemosol (HML-T)
September 5, 2001
High valuation and delay on trials was a downer.
Showing 31 to 45 of 78 entries